Blood in the Urine: When Is It a Bladder Warning Sign?
Blood in the urine—whether you can see it or not—should never be ignored. Here’s what hematuria can mean, when it may signal bladder cancer, how doctors evaluate it, and when to seek urgent care.
Why blood in the urine should not be ignored
If you notice pink, red, or tea-colored urine, or if your doctor tells you there’s blood in your urine on a lab test, it deserves attention. Blood in the urine—called hematuria—can have many causes. Most are not cancer. But in some cases, especially in older adults or people with a history of smoking, it can be an early sign of bladder cancer.
The practical takeaway: Any visible blood in the urine should be evaluated promptly, even if it goes away. Microscopic blood found on a routine urine test may also need follow-up depending on your age and risk factors.
What hematuria is: visible vs. microscopic
Hematuria means red blood cells are present in the urine.
- Gross (visible) hematuria: You can see the color change—pink, red, cola, or tea-colored urine.
- Microscopic hematuria: The urine looks normal, but blood cells are detected under a microscope or on a dipstick test.
According to MedlinePlus, blood in the urine may appear once or come and go. Even if it happens only once and then clears, it still warrants medical evaluation.
Most common causes (and why cancer is not the most common)
It’s important not to jump to worst-case conclusions. The most frequent causes of hematuria are not cancer.
Common causes include:
- Urinary tract infections (UTIs)
- Kidney stones
- Enlarged prostate (in men)
- Recent vigorous exercise
- Certain medications, including blood thinners
- Kidney diseases or inflammation
UTIs, for example, can cause burning with urination, urgency, and sometimes fever. Kidney stones often cause severe side or back pain. These conditions are much more common than bladder cancer.
Still, as the National Cancer Institute (NCI) notes, blood in the urine is the most common symptom of bladder cancer. That’s why it should never be dismissed without checking.
Bladder cancer risk factors and symptom patterns
Bladder cancer usually affects older adults and is more common in men. The CDC and NCI identify smoking as the leading risk factor. Chemicals in tobacco smoke enter the bloodstream, are filtered by the kidneys, and collect in the urine—exposing the bladder lining over time.
Other risk factors include:
- Age over 55
- Male sex
- Occupational exposure to certain chemicals (such as in dye, rubber, or leather industries)
- Prior pelvic radiation or certain chemotherapy drugs
- Chronic bladder irritation
Bladder cancer can cause:
- Painless blood in the urine
- Urinary urgency or frequency
- Burning with urination without infection
Importantly, many people with early bladder cancer feel otherwise well. There may be no pain. That’s one reason delays in evaluation can postpone diagnosis.
Screening vs. symptom evaluation: what USPSTF says
There’s an important distinction between screening and evaluation of symptoms.
The U.S. Preventive Services Task Force (USPSTF) states that there is not enough evidence to recommend routine screening for bladder cancer in adults who have no symptoms. That means doctors are not advised to test everyone for bladder cancer if they feel fine and have no warning signs.
However, this does not apply to people with symptoms. If you have visible blood in your urine—or persistent microscopic hematuria—medical evaluation is recommended. That is diagnostic testing, not screening.
What to expect at the doctor’s office
If you report blood in your urine, your primary care clinician will usually begin with:
- Urinalysis to confirm blood and check for infection
- Urine culture if a UTI is suspected
If infection is found, it’s treated first. After treatment, urine is often rechecked to ensure the blood has cleared.
If blood persists—or if no infection is present—further evaluation may include:
- Imaging: CT scan (often CT urogram) or ultrasound to look at kidneys and urinary tract
- Cystoscopy: A urologist uses a thin camera inserted through the urethra to directly examine the bladder lining
The American Academy of Family Physicians (AAFP) notes that evaluation is often risk-based. Age, smoking history, and the amount of blood seen influence how extensive the workup should be.
Cystoscopy is considered the gold standard for evaluating the bladder itself. While generally safe, it is an invasive procedure and may cause temporary discomfort or bleeding.
When to seek urgent or emergency care
Some symptoms require immediate attention. Seek urgent or emergency care if you have:
- Heavy bleeding or visible clots
- Inability to urinate with a painful, full bladder
- Fever (100.4°F or higher) with back or flank pain
- Dizziness, fainting, or weakness
These can signal serious infection, obstruction, or significant blood loss.
Insurance and access considerations in the U.S.
Under most U.S. insurance plans, diagnostic testing for symptoms—such as blood in the urine—is covered as medically necessary care. That differs from preventive screening, which follows specific coverage rules.
If you see visible blood, contact your primary care clinician promptly. They can often arrange testing and refer you to a urologist if needed. If access is limited, community health centers and federally qualified health centers can provide evaluation and referrals.
Why timely evaluation matters
Infections and stones are common and treatable. But if hematuria is caused by something more serious—such as bladder cancer—earlier diagnosis generally allows for simpler and more effective treatment.
The key message for readers: Do not ignore blood in your urine, even if it happens once and then stops. Most causes are not cancer, but ruling out serious conditions is important—especially if you are over 55 or have a history of smoking.
Primary care exists to sort out these questions early. When in doubt, make the appointment.
Sources
- https://www.cancer.gov/types/bladder
- https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/bladder-cancer-screening
- https://medlineplus.gov/ency/article/003138.htm
- https://www.aafp.org/pubs/afp/issues/2013/1201/p747.html
- https://www.cdc.gov/cancer/bladder/
This article is for general informational purposes only and is not medical advice. Research findings can be early, limited, or subject to change as new evidence emerges. For personal guidance, diagnosis, or treatment, consult a licensed clinician. For current outbreak or public health guidance, follow your local health department, the CDC, or another relevant public health authority.
